NASDAQ · CLMT

Calumet, Inc.

$41.69 -$1.13 (-2.64%) 1D After hours

Key Metrics

$3.73B
Market cap
P/E · TTM
$4.17B
Revenue · TTM
−$188.80M
Net income
EPS · TTM $-2.18
Dividend yield
Free cash flow $4.10M
Beta · 1Y 0.09
EBITDA · TTM
Gross margin 5.7%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    Money has been moving into its sector (Energy).

    Energy has run +9.0 points vs SPY over four weeks, ranking 10→1→1→1 of 11 sectors — this stock trades inside that current.

    RECEIPT: ROTATION MAP, LIVE ↗
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Feb 27
    The stock moved -10.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 27
  • Feb 13
    The stock moved +10.1% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 13

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$3.73B
Enterprise value$5.93B
Shares outstanding87.1M
52-wk range$12.94 – $45.20
Avg volume · 20D463.0K
Net cash −$2.19B
Book value / share$-12.07
IndustryPetroleum Refining
ExchangeNASDAQ
About Calumet, Inc.
IPO dateJan 26, 2006
Employees1540

Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.89
P/FCF910.16
EV/EBITDA
EV/Sales1.42
Graham №

Profitability

Gross 5.7%
Operating -7.3%
Net -4.5%
FCF 0.1%
ROE / ROIC 21.5% · -16.4%

Financial Health

Current ratio0.96
Quick ratio0.58
Debt / equity-2.24
Debt / EBITDA
Net cash −$2.19B
Working capital−$35.20M

Cash Flow · TTM

Operating CF $52.00M
Capex −$47.90M
Free cash flow $4.10M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

6 / 9
Middling fundamentals · 6 of 9 signals passing

Altman Z-Score

0.8
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings